Kernodle & Katon Asset Management Group, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 131 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Kernodle & Katon Asset Management Group, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$13,000
-7.1%
1,9890.0%0.01%0.0%
Q4 2016$14,000
+16.7%
1,989
+60.5%
0.01%
+14.3%
Q3 2016$12,000
+9.1%
1,2390.0%0.01%
-30.0%
Q2 2016$11,0000.0%1,2390.0%0.01%0.0%
Q1 2016$11,000
+37.5%
1,2390.0%0.01%
+25.0%
Q4 2015$8,0001,2390.01%
Other shareholders

There were no reported owners of INOVIO PHARMACEUTICALS INC in Q2 2016.

NameSharesValueWeighting ↓
View complete list of INOVIO PHARMACEUTICALS INC shareholders